70 likes | 96 Views
The global myocardial ischemia market is expected to reach a market value of USD 50,120.3 million by 2023 with a CAGR of 6.0% from 2017-2023.
E N D
Summary Global Myocardial Ischemia Market Research Report 2023. The global myocardial ischemia market is expected to reach a market value of USD 50,120.3 million by 2023 from USD 31,268.9 million in 2015 and is expected to register a CAGR of 6.0 % during the forecast period from 2017 to 2023. In 2017, the Americas held the highest share of the market at 35.7%, followed by Europe and Asia-Pacific with shares of 29.3% and 23.5%, respectively.
Key Highlights • Major Players: Some of the key players operating in global myocardial ischemia market: • TaxusCardium • ViroMedCo. Ltd • Edwards Lifesciences Corporation • Daiichi Sankyo Company Limited • Boston Scientific Corporation • Merck KGaA • Novartis AG • Get key facts, key financials, key financial ratios, revenues & profitability, and assets & liabilities for these key players.
Major Drivers • The high prevalence of coronary heart disorders, increasing cases of diabetes, and changing lifestyles are factors expected to drive the market demand over the forecast period2017-2023. • High prevalence of coronary heart disease. • Rising prevalence of diabetes • Lifestyle changes • Drivers Impact Analysis
Related Reports • Global Myocardial Ischemia Market Research Report 2018 • Myocardial Ischemia Global Clinical Trials Review, H1, 2018 • Global Wireless Healthcare Market
Thank You ! For More Details Please visit www.aarkstore.com +91 7710006788 | contact@aarkstore.com